会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • IMINO OXYPHENYL ACETIC ACID DERIVATIVES, METHODS AND INTERMEDIATES FOR THEIR PREPARATION AND USE THEREOF
    • IMINOOXYPHENYLESSIGSÄUREDERIVATE,工艺和中间产品和使用
    • WO1997024317A1
    • 1997-07-10
    • PCT/EP1996005642
    • 1996-12-16
    • BASF AKTIENGESELLSCHAFTGROTE, ThomasSAUTER, HubertKIRSTGEN, ReinhardBAYER, HerbertMÜLLER, RuthMÜLLER, BerndOBERDORF, KlausGRAMMENOS, WassiliosGÖTZ, NorbertRACK, MichaelHARREUS, AlbrechtRÖHL, FranzAMMERMANN, EberhardHARRIES, VolkerLORENZ, GiselaSTRATHMANN, Siegfried
    • BASF AKTIENGESELLSCHAFT
    • C07C251/60
    • C07C251/60C07C2601/10C07C2601/14
    • The invention relates to 2-imino oxyphenyl acetic acid derivatives of formula (I) in which the substituents and the index have the following meanings: R is C(CO2CH3)=NOCH3 (Ia), C(CONHCH3)=NOCH3 (Ib), C(CONH2)=NOCH3 (Ic), C(CO2CH3)=CHOCH3 (Id), or C(CO2CH3)=CHCH3 (Ie); R is cyano, nitro, halogen, alkyl, alkyl halide or alkoxy; m is 0,1 or 2; R is hydrogen, cyano, hydroxy, halogen, alkyl, alkyl halide, alkoxy alkyl, alkoxy, alkoxy halide, alkylthio, cyclopropyl, alkenyl, optionally substituted aryloxy alkyl, benzyl or benzyloxy; R is hydrogen, cyano, optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, heterocyclyl, aryl and hetaryl, optionally substituted alkoxy, alkenyloxy, alkinyloxy, cycloalkoxy, heterocyclyloxy, aryloxy and hetaryloxy, optionally substituted arylthio and hetarylthio; -Q-C(R )=N-Y -R or -Q-O-N=CR R ; R and R together with the carbon atom to which they are bound, are an optionally substituted four to eight-membered ring which can contain in addition to carbon atoms one or two oxygen atoms and/or sulphur atoms and/or NH- and/or N(C1-C4-alkyl)groups; wherein R and R are not simultaneously bound via heteroatoms to the carbon atom. The invention also relates to the salts of said derivatives, methods and intermediates for their preparation and use thereof.
    • 式(I),2-Iminooxyphenylessigsäurederivate其中取代基和指数具有以下含义:R t <1> C(CO 2 CH 3)= NOCH 3(Ia)中,C(CONHCH 3)= NOCH 3(Ib)中,C(CONH 2)= NOCH 3(Ic)中,C(CO2CH3)= CHOCH 3(同上)或C(CO2CH3)= CHCH3(IE); [R <2>氰基,硝基,卤素,烷基,卤代烷基或烷氧基; m是0,1或2; [R <3>是氢,氰基,羟基,卤素,烷基,卤代烷基,烷氧基烷基,烷氧基,卤代烷氧基,烷硫基,环丙基,链烯基,未取代的或取代的。 芳氧基烷基,苄基或苄氧基; [R <4>是氢,氰基,未取代的或取代的。 烷基,烯基,炔基,环烷基,杂环基,芳基和杂芳基; 未取代的或取代的。 烷氧基,烯氧基,炔氧基,环烷氧基,杂环氧基,芳氧基和杂芳氧基; 未取代的或取代的。 芳和杂芳硫基; -Q-C(R <5>)= N-Y <1> -R <6>或-Q-O-N = CR <7> - [R <8>; [R <3>和R <4>的碳原子一起形成它们所连接的未取代或取代的。 四到八位元环,其除了碳原子,一个或两个氧和/或硫原子和/或NH和/或N(C1-C4烷基)可以含有基团; 其中R <3>和R <4>不同时经由键合至的碳原子键合的杂原子; 和它们的盐,过程和它们的制备方法和它们的使用的中间体。
    • 10. 发明申请
    • FUNGICIDAL MIXTURES
    • OXIMETHERCARBONSÄUREAMIDS与吡咯衍生物杀菌剂MIXTURES
    • WO1997006678A1
    • 1997-02-27
    • PCT/EP1996003358
    • 1996-07-31
    • BASF AKTIENGESELLSCHAFTSCHWALGE, BarbaraMÜLLER, RuthBAYER, HerbertSAUTER, HubertSAUR, ReinholdSCHELBERGER, KlausAMMERMANN, EberhardLORENZ, GiselaSTRATHMANN, Siegfried
    • BASF AKTIENGESELLSCHAFT
    • A01N37/50
    • A01N37/50A01N55/00A01N47/38A01N43/653A01N43/50A01N2300/00
    • A fungicidal mixture contains synergistically effective amounts of (a) an oximether carboxylic acid amide having the formula (I), in which R stands for hydrogen or halogen, and (b) an azol derivative (II) selected from the group of compounds II.1 to II.17, namely 1-(2 RS ,4 RS ;2 RS ,4 SR )-4-brom-2-(2,4-dichlorophenyl)tetrahydrofuryl)-1H-1,2,4-triazol (II.1), 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H,1,2,4-triazol-1-yl)-butan-2-ol (II.2), (+/-)-4-chloro-4-(4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl)-phenyl-4-chlorophenylether (II.3); (E)-(R,S)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol (II.4); (Z)-2-(1H-1,2,4-triazol-1-ylmethyl)-2-(4-fluorophenyl)-3-(2-chlorophenyl)-oxirane (II.5); 4-(4-chlorophenyl)-2-phenyl-2-(1H-1,2,4-triazolylmethyl)-butyronitril (II.6); 3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one (II.7); bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-yl-methyl)silane (II.8); (R,S)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)-hexan-2-ol (II.9); (1 RS ,5 RS ;1 RS ,5 RS )-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol (II.10); N-propyl-N-(2-(2,4,6-trichlorophenoxy)ethyl)imidazol-1-carboxamide (II.11); (+/-)-1-(2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl-methyl)-1H-1,2,4-triazol (II.12); (R,S)-1-(4-chlorophenyl)-4,4-dimethyl-3-(1H,1,2,4-triazol-1-ylmethyl)-pentan-3-ol (II.13); (+/-)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-yl)-propyl-1,1,2,2-tetrafluorethylether (II.14); (E)-1-1(1-((4-chloro-2-(trifluoromethyl)-phenyl)imino)-2-propoxyethyl)-1H-imidazol (II.15); (RS)-2,4'-difluoro- alpha -(1H-1,2,4-triazol-1-ylmethyl)-benzyhdryl-alcohol (II.16); 2-p-chlorophenyl-2-(1H-1,2,4-triazol-1-ylmethyl)-hexanenitril (II.17).
    • 含有a)式(I),其中R代表氢或卤素的肟醚甲酰胺的杀真菌混合物,和b)从该组化合物中选择的吡咯衍生物II II.1到II.17:1 - [(2- RS ,4 RS 2 RS ,4 SR ) - 4-溴-2-(2,4-二氯苯基 )四氢呋喃基〕-1H-1,2,4-三唑(II.1); 2-(4-氯苯基)-3-环丙基-1-(1H-1,2,4-三唑-1-基) - 丁-2-醇(II.2); (+/-) - 4-氯-4- [4-甲基-2-(1H-1,2,4-三唑-1-基甲基)-1,3-二氧戊环-2-基] - 苯基-4- 氯苯基醚(II.3); (E) - (R,S)-1-(2,4-二氯苯基)-4,4-二甲基-2-(1H-1,2,4-三唑-1-基)戊-1-烯-3- 醇(II.4); (Z)-2-(1H-1,2,4-三唑-1-基甲基)-2-(4-氟苯基)-3-(2-氯苯基) - 环氧乙烷(II.5); 4-(4-氯苯基)-2-苯基-2-(1H-1,2,4-三唑基甲基)丁腈(II.6); 3-(2,4-二氯苯基)-6-氟-2-(1H-1,2,4-三唑-1-基)喹唑啉-4(3H) - 酮(II.7); 双(4-氟苯基)(甲基)(1H-1,2,4-三唑-1-基 - 甲基)硅烷(II.8); (R,S)-2-(2,4-二氯苯基)-1-(1H-1,2,4-三唑-1-基) - 己-2-醇(II.9); (1 RS 5 RS 1 RS 5 SR ) - 5-(4-氯苄基) - 2,2-二甲基-1-(1H-1,2,4-三唑-1-基甲基)环戊醇(II.10); N-丙基-N- [2-(2,4,6-三氯苯氧基)乙基]咪唑-1-羧酰胺(II.11); (+/-) - 1- [2-(2,4-二氯苯基)-4-丙基-1,3-二氧戊环-2-基 - 甲基] -1H-1,2,4-三唑(.12) ; (R,S)-1-(4-氯苯基)-4,4-二甲基-3-(1H-1,2,4-三唑-1-基甲基)戊烷-3-醇(二,13); (+/-) - 2-(2,4-二氯苯基)-3-(1H-1,2,4-三唑基) - 丙基-1,1,2,2-四氟乙基醚(二.14); 和(E)-1- [1 - [[4-氯-2-(三氟甲基]苯基]亚氨基] -2-丙氧基乙基] -1H-咪唑(II.15),(RS)-2,4' 二氟α - (1H-1,2,4-三唑-1-基甲基) - 二苯甲基醇(二,16); 2-对氯苯基-2-(1H-1,2,4-三唑-1- 在协同有效量基甲基)-hexanenitril(二.17)。